Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 5, 2014

Peripheral blood lymphocytes from patients with bipolar disorder demonstrate apoptosis and differential regulation of advanced glycation end products and S100B

  • Paraskevi Moutsatsou , James N. Tsoporis EMAIL logo , Vasileios Salpeas , Ekaterini Bei , Basel Alevizos , Chrysoula Anagnostara , Shehla Izhar , Gerald Proteau , Emmanouil Rizos , Erifili Hatziagelaki , Ioannis K. Toumpoulis , Ioannis K. Rizos and Thomas G. Parker

Abstract

Background: This study addresses the expression of the glycosylated proteins known as advanced glycation end products (AGEs), the calcium binding protein S100B and the apoptotic parameters cytochome c and caspase-3 activity in peripheral lymphocyte cytosolic extracts from a sample of bipolar disorder (BD) patients and healthy (control) subjects.

Methods: Cross-sectional study of 35 patients with a clinical diagnosis of bipolar disease (10 euthymic, 12 depressed, 13 manic) and 10 healthy control subjects. Lymphocytes were used as a surrogate model in BD diagnosis and treatment. AGEs and S100B in lymphocyte cell extracts were measured by commercially available enzyme-linked immunosorbent assay.

Results: AGEs were lower in all BD patients compared to healthy subjects. Depressed patients had approximately two-fold higher S100B levels compared to healthy subjects. Manic and depressed BD patients had increased superoxide dismutase mRNA levels. Apoptosis as measured by BAX/Bcl2 ratio, cytochrome c release, caspase-3 activity was increased in manic and depressed patients compared to healthy subjects. In the depressed patients, S100B levels correlated with cytochrome c release.

Conclusions: In conclusion, our study shows decreased AGEs and increased S100B levels and caspase down-stream apoptosis in peripheral lymphocytes of BD patients that may underlie disease etiopathogenesis.


Corresponding author: James N. Tsoporis, Division of Cardiology, Department of Medicine, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, 30 Bond Street, Toronto, Ontario, Canada, Phone: +1 416-864-6060X77625, Fax: +1 416-864-6034, E-mail:
aParaskevi Moutsatsou and James N. Tsoporis contributed equally to this work.

Acknowledgments

This project is financed from an operating grant to TGP from the Canadian Institutes of Health Research.

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article. Research funding played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

References

1. Hains AB, Arnsten AF. Molecular mechanisms of stress-induced prefrontal cortical impairment: implications for mental illness. Learn Mem 2008;15:551–64.10.1101/lm.921708Search in Google Scholar PubMed

2. Gigante AD, Young LT, Yatham LN, Andreazza AC, Nery FG, Grinberg LT, et al. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 2011;14: 1075–89.10.1017/S146114571000146XSearch in Google Scholar PubMed

3. Szuster-Ciesielska AM, Słotwińska M, Stachura A, Marmurowska-Michałowska H, Dubas-Slemp H, Bojarska-Junak A, et al. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008;32: 686–94.10.1016/j.pnpbp.2007.11.012Search in Google Scholar PubMed

4. Hosokawa T, Momose T, Kasai K. Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:243–50.10.1016/j.pnpbp.2008.11.014Search in Google Scholar PubMed

5. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004;61:450–8.10.1001/archpsyc.61.5.450Search in Google Scholar PubMed

6. Naydenov AV, MacDonald ML, Ongur D, Cotto JJ. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry 2007;64:555–64.10.1001/archpsyc.64.5.555Search in Google Scholar PubMed

7. Brownlee M. Advanced glycosylation in diabetes and aging. Annu Rev Med 1995;46:223–34.10.1146/annurev.med.46.1.223Search in Google Scholar PubMed

8. Mahali S, Raviprakash N, Raghavendra PB, Manna SK. Advanced glycation end products (AGEs) induce apoptosis via a novel pathway: involvement of Ca2+ mediated interleukin-8 protein. J Biol Chem 2011;286:34903–13.10.1074/jbc.M111.279190Search in Google Scholar PubMed PubMed Central

9. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, et al. S100B’s double life: intracellular regulator and extracellular signal. Intracellular and extracellular roles of S100 proteins. Biochim Biophys Acta 2009;1793:1008–22.10.1016/j.bbamcr.2008.11.009Search in Google Scholar PubMed

10. Scotto C, Deloulme JC, Rousseau D, Chambaz E, Baudier J. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol Cell Biol 1998;18:4272–81.10.1128/MCB.18.7.4272Search in Google Scholar PubMed PubMed Central

11. Wiesmann M, Wandinger KP, Missler U, Eckhoff D, Rothermundt M, Arolt V, et al. Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry 1999;45:1508–11.10.1016/S0006-3223(98)00217-0Search in Google Scholar

12. Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Rudolf S, et al. S100B and response to treatment in major depression: a pilot study. Eur Neuropsychopharmacol 2003;13:235–9.10.1016/S0924-977X(03)00016-6Search in Google Scholar

13. Steiner J, Walter M, Wunderlich MT. A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE. Biol Psychiatry 2009;13:1107–10.10.1016/j.biopsych.2008.10.044Search in Google Scholar PubMed

14. Suchankova P, Klang J, Cavanna C, Holm G, Nilsson S, Jonsson EG, et al. Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism? J Psychiatry Neurosci 2012;37:122–8.10.1503/jpn.110024Search in Google Scholar PubMed PubMed Central

15. Daborg J, von Otter M, Sjölander A, Nilsson S, Minthon L, Gustafson DR, et al. Association of the RAGE G82S polymorphism with Alzheimer′s disease. J Neural Transm 2010;117:861–7.10.1007/s00702-010-0437-0Search in Google Scholar PubMed PubMed Central

16. Ponath G, Schettler C, Kaestener F, Voigt B, Wentker D, Arolt V, et al. S100B effects on astrocytes are mediated via RAGE. J Neuroimmunol 2007;184:214–22.10.1016/j.jneuroim.2006.12.011Search in Google Scholar PubMed

17. Steiner J, Bernstein HG, Bogerts B, Gos T, Richter-Landsberg C, Wunderlich MT, et al. S100B is expressed in, and released from, OLN-93 oligodendrocytes: influence of serum and glucose deprivation. Neuroscience 2008;154:496–503.10.1016/j.neuroscience.2008.03.060Search in Google Scholar PubMed

18. Steiner J, Marquardt N, Pauls I, Schiltz I, Rahmoune H, Bahn S, et al. Human CD8(+) T cells and NK cells express and secrete S100B upon stimulation. Brain Behav Immun 2011;25:1233–41.10.1016/j.bbi.2011.03.015Search in Google Scholar PubMed

19. Schroeter ML, Abdul-Khaliq H, Sacher J, Steiner J, Blasig IE, Mueller K. Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc Psychiatry Neurol 2010;2010:780645.10.1155/2010/780645Search in Google Scholar PubMed PubMed Central

20. Takahashi K, Yoshino T, Hayashi K, Sonobe H, Ohtsuki Y. S-100 beta positive human T lymphocytes: their characteristics and behavior under normal and pathologic conditions. Blood 1987;70:214–20.10.1182/blood.V70.1.214.214Search in Google Scholar

21. Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, et al. DNA damage in bipolar disorder. Psychiatry Res 2007;153:27–32.10.1016/j.psychres.2006.03.025Search in Google Scholar

22. Politi P, Brondino N, Emanuele E. Increased proapoptotic serum activity in patients with chronic mood disorders. Arch Med Res 2008;39:242–5.10.1016/j.arcmed.2007.07.011Search in Google Scholar

23. Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM, et al. Mitochondrial involvement in psychiatric disorders. Ann Med 2008;40:281–95.10.1080/07853890801923753Search in Google Scholar

24. Kim H-W, Rapoport SI, Rao JS. Altered expressions of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis 2010;37:596–603.10.1016/j.nbd.2009.11.010Search in Google Scholar

25. Bei E, Salpeas V, Pappa D, Anagnostara C, Alevizos V, Moutsatsou P. Phosphorylation status of glucocorticoid receptor, heat shock protein 70, cytochrome c and Bax in lymphocytes of euthymic, depressed and manic bipolar patients, Psychoneuroendocrinol 2009;34:1162–75.10.1016/j.psyneuen.2009.03.002Search in Google Scholar

26. Bei ES, Salpeas V, Alevizos B, Anagnostara C, Pappa D, Moustatsou P. Pattern of heat shock factor and heat shock protein expression in lymphocytes of bipolar patients: increased HSP70-glucocorticoid receptor heterocomplex. J Psychiatr Res 2013;47:1725–36.10.1016/j.jpsychires.2013.07.018Search in Google Scholar

27. Lowy MT. Reserpine-induced decrease in type I and II corticosteroid receptors in neuronal and lymphoid tissues of adrenalectomized rats. Neuroendocrinol 1990;51:190–6.10.1159/000125336Search in Google Scholar

28. Spencer RL, Miller AH, Stein M, McEwen BS, Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue. Brain Res 1991;549:236–46.10.1016/0006-8993(91)90463-6Search in Google Scholar

29. First MB, Spitzer RL, Gibbon M. Structured clinical interview for DSM-IV Axis I disorders, research version. Biometrics Research: New York, 1997.Search in Google Scholar

30. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278–96.10.1111/j.2044-8260.1967.tb00530.xSearch in Google Scholar PubMed

31. Young RC, Briggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429–35.10.1192/bjp.133.5.429Search in Google Scholar PubMed

32. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with “miniextracts”, prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.10.1093/nar/17.15.6419Search in Google Scholar

33. Tsoporis JN, Izhar S, Leong-Poi H, Desjardins JF, Huttunen HJ, Parker TG. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction. Circ Res 2010;106:93–101.10.1161/CIRCRESAHA.109.195834Search in Google Scholar

34. Li J, Liu D, Sun L, Lu Y, Zhang Z. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci 2012;317:1–5.10.1016/j.jns.2012.02.018Search in Google Scholar

35. Morimoto RI, Kline MP, Bimston DN. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 1997;32:17–29.Search in Google Scholar

36. Poppek D, Grune T. Proteasomal defense of oxidative protein modifications. Antioxid Redox Signal 2006;8:173–84.10.1089/ars.2006.8.173Search in Google Scholar

37. Schmid K, Haslbeck M, Buchner J, Somoza V. Induction of heat shock proteins and the proteasome system by casein-N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)lysine in Caco-2 cells. Ann NY Acad Sci 2008;1126:257–61.10.1196/annals.1433.062Search in Google Scholar

38. Verbeke P, Clark BF, Rattan SI. Reduced levels of oxidized and glycoxidized proteins in human fibroblasts exposed to repeated mild heat shock during serial passaging in vitro. Free Radic Biol Med 2001;31:1593–602.10.1016/S0891-5849(01)00752-3Search in Google Scholar

39. Bassi AM, Ledda S, De Pascale MC, Penco S, Rossi S, Odetti P, et al. Antioxidant status in J774A.1 macrophage cell line during chronic exposure to glycated serum. Biochem Cell Biol 2005;83:176–87.10.1139/o05-024Search in Google Scholar

40. Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan E, Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Function 2002;293:2528–30.10.1002/cbf.940Search in Google Scholar

41. Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004;19:89–95.10.1097/00004850-200403000-00006Search in Google Scholar

42. Ranjeker PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psych Res 2003;121:109–22.10.1016/S0165-1781(03)00220-8Search in Google Scholar

43. Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, et al. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 2007;41:523–9.10.1016/j.jpsychires.2006.07.013Search in Google Scholar

44. Machado-Vieira R, Lara DR, Portela LV, Gonçalves CA, Soares JC, Kapczinski F, et al. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Eur Neuropsychopharmacol 2002;12:269–72.10.1016/S0924-977X(02)00029-9Search in Google Scholar

45. Ferrari C, Sansoni P, Rowden G. One half of the CD11b+ human peripheral blood T lymphocytes coexpresses the S-100 protein. Clin Exp Immunol 1988;72:357–61.Search in Google Scholar

46. Qi LY, Xiu MH, Chen da C, Wang F, Kosten TA, Kosten TR, et al. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics. Neursci Lett 2009;22:113–7.Search in Google Scholar

47. Steiner J, Schroeter ML, Schiltz K, Bernstein HG, Műller UJ, Richter-Landsberg C, et al. Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience 2010;2:1025–31.10.1016/j.neuroscience.2010.03.010Search in Google Scholar

48. Zhang XY, Xiu MH, Song C, Chen da C, Wu GY, Haile CN, et al. Increased serum S100B in never-medicated and medicated schizophrenic paients. J Psych Res 2010;44:1236–40.10.1016/j.jpsychires.2010.04.023Search in Google Scholar

49. Nardin P, Tramontina AC, Quincozes-Santos A, Tortorelli LS, Lunardi P, Klein PR, et al. In vitro S100B secretion is reduced by apomorphine: effects of antipsychotics and antioxidants. Prog Neuropsychopharmacol Biol Psychiatry 2011;1:1291–6.10.1016/j.pnpbp.2011.04.004Search in Google Scholar

50. Eilat E, Mendlovic S, Doron A. Increased apoptosis in patients with major depression: a preliminary study. J Immunol 1996;163:533–4.10.4049/jimmunol.163.1.533Search in Google Scholar

51. Hu J, Van Eldik LJ. S100B induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim Biophys Acta 1996;1313:239–45.10.1016/0167-4889(96)00095-XSearch in Google Scholar

52. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J Biol Chem 2000;275:40096–105.10.1074/jbc.M006993200Search in Google Scholar PubMed

53. Tubaro C, Arcuri C, Giambanco I, Donato R. S100B in myoblasts regulates the transition from activation to quiescence to activation, and reduces apoptosis. Biochim Biophys Acta 2011;1813:1092–104.10.1016/j.bbamcr.2010.11.015Search in Google Scholar PubMed

54. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 2007;43:31317–31.10.1074/jbc.M703951200Search in Google Scholar PubMed

55. Lin J, Yang Q, Wilder PT, Carrier F, Weber DJ. The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma. J Biol Chem 2010;285:27487–98.10.1074/jbc.M110.155382Search in Google Scholar PubMed PubMed Central

56. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of S100 proteins. Curr Mol Med 2012;12:1–34.10.2174/1566524011307010024Search in Google Scholar

57. Xia Z, DePierre JW, Nassberger L. The tricyclic antidepressants clomipramine and citalopram induce apoptosis in cultured human lymphocytes. J Pharm Pharmacol 1996;48:115–6.10.1111/j.2042-7158.1996.tb05889.xSearch in Google Scholar PubMed

Received: 2013-11-12
Accepted: 2014-1-10
Published Online: 2014-2-5
Published in Print: 2014-7-1

©2014 by Walter de Gruyter Berlin/Boston

Downloaded on 5.3.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2013-0978/html
Scroll to top button